- Home
- OSUR vs JRS Comparison
OSUR vs JRS Comparison
Compare OSUR & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- JRS
- Stock Information
- Founded
- OSUR 2000
- JRS 2001
- Country
- OSUR United States
- JRS United States
- Employees
- OSUR N/A
- JRS N/A
- Industry
- OSUR Medical/Dental Instruments
- JRS Finance/Investors Services
- Sector
- OSUR Health Care
- JRS Finance
- Exchange
- OSUR Nasdaq
- JRS Nasdaq
- Market Cap
- OSUR 223.0M
- JRS 231.7M
- IPO Year
- OSUR 1986
- JRS N/A
- Fundamental
- Price
- OSUR $2.81
- JRS $7.91
- Analyst Decision
- OSUR Hold
- JRS
- Analyst Count
- OSUR 1
- JRS 0
- Target Price
- OSUR $3.00
- JRS N/A
- AVG Volume (30 Days)
- OSUR 749.5K
- JRS 86.6K
- Earning Date
- OSUR 05-07-2025
- JRS 01-01-0001
- Dividend Yield
- OSUR N/A
- JRS 8.87%
- EPS Growth
- OSUR N/A
- JRS N/A
- EPS
- OSUR N/A
- JRS N/A
- Revenue
- OSUR $161,626,000.00
- JRS N/A
- Revenue This Year
- OSUR N/A
- JRS N/A
- Revenue Next Year
- OSUR $6.87
- JRS N/A
- P/E Ratio
- OSUR N/A
- JRS N/A
- Revenue Growth
- OSUR N/A
- JRS N/A
- 52 Week Low
- OSUR $2.36
- JRS $5.95
- 52 Week High
- OSUR $4.98
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- OSUR 51.01
- JRS 52.19
- Support Level
- OSUR $2.71
- JRS $7.69
- Resistance Level
- OSUR $3.01
- JRS $7.98
- Average True Range (ATR)
- OSUR 0.16
- JRS 0.14
- MACD
- OSUR 0.05
- JRS 0.00
- Stochastic Oscillator
- OSUR 68.46
- JRS 63.46
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.